Who owns T-Therapeutics?

T-Therapeutics is currently owned by BGF, through BGF Early Stage Fund, since 2023.

When did BGF acquire T-Therapeutics?

BGF acquired T-Therapeutics in 2023 (active for 3 years).

Home/Companies/Healthcare/T-Therapeutics

T-Therapeutics

Healthcare·

UK·Active·3yr hold

T-Therapeutics is a healthcare / biotech company, headquartered in United Kingdom.

Entry

2023

Hold

3yr

Status

Active

Est. EV

–

Most recent investor

BGF

2 ownership periods

Key facts

HQUnited Kingdom

SectorHealthcare / Biotech

A next-generation T-cell receptor (TCR) company, T-Therapeutics is reshaping the clinical landscape for cancer and autoimmune diseases.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from BGF Early Stage Fund

Other portfolio companies in the same fund.

AimBrain

Active

TMT

Cambridge GaN Devices

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings